Female Health Company December 29, 2005 Form 8-K
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
__________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): December 29,
2005
|
THE
FEMALE HEALTH COMPANY
|
|
(Exact
name of registrant as specified in its charter)
|
|
Wisconsin
|
|
(State
or other jurisdiction of
incorporation)
|
|
1-13602
|
|
39-1144397
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer I.D. Number)
|
|
515
North State Street, Suite 2225
Chicago,
Illinois
|
|
60610
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
312-595-9123
|
|
(Registrant's
telephone number, including area code)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
o
Soliciting
material
pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the
Exchange
Act (17 CFR 240.13e-4(c))
Section
2 - Financial Information
Item
2.02 Results
of Operations and Financial Condition
On
December 29, 2005, The Female Health Company issued a press release (the "Press
Release") announcing results for the quarter and fiscal year ended
September 30, 2005. A copy of the Press Release is attached as Exhibit 99.1
to this report. The attached Exhibit 99.1 is furnished pursuant to Item 2.02
of
Form 8-K.
The
information in this Form 8-K and the Exhibit attached hereto shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934,
nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly
set forth by specific reference in such filing.
Section
9 - Financial Statements and Exhibits
Item
9.01 Financial
Statements and Exhibits
(d)
Exhibits
The following exhibit is furnished herewith:
Exhibit 99.1
- Press Release of The Female Health Company, issued December 29,
2005.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
THE
FEMALE HEALTH
COMPANY
Date:
December 30, 2005
BY /s/
O.B.
Parrish
O.B.
Parrish,
Chairman and
Chief
Executive Officer